Apolipoprotein (apo) E4 is a risk factor for Alzheimer's disease, compared to wild-type apoE3. The mechanism(s) is unknown. One possibility, demonstrated in peripheral tissue cell lines, is that apoE stimulates nitric oxide synthase (NOS) via a receptor-dependent signalling pathway and that apoE4 generates inappropriate amounts of NO compared to apoE3. Prior to biochemical investigations, we have quantified the expression of several candidate receptor genes, including low-density lipoprotein (LDL)-receptor family members and scavenger receptor class B, types I and II (SR-BI/II), as well as the three NOS isoenzymes and protein kinase B (Akt), in 38 human cell lines, of which 12 derive from brain. Expression of apoE receptor 2 (apoER2), a known signalling receptor in brain, was readily detected in SH-SY-5Y
Introduction
Alzheimer's disease (AD) is the most common neurodegenerative disease and accounts for approximately two-thirds of all cases of dementia [1] . Genetic linkage analysis has identified highly penetrant missense mutations in three genes in familial forms of AD, which directly affect disease pathology hallmarks: the amyloid precursor protein (APP) gene on chromosome 21 , presenilin-1 (PS-1) on chromosome 14 and presenilin-2 (PS-2) on chromosome 1 [2] [3] [4] .
Despite this, 90-95% of AD cases are late-onset, occurring sporadically with no observable mutation in the APP or presenilin genes [5, 6] . Genes involved in sporadic AD most likely affect disease progression indirectly by modulating one or more metabolic functions in brain relating to normal biosynthesis and homeostasis.
Over 10 years ago, the ε4 allele of apolipoprotein E (apoE) was identified as a key susceptibility gene in development of late-onset AD [7, 8] . Plasma apoE helps regulate cholesterol metabolism by high-affinity receptor binding, which initiates uptake of lipoprotein particles for lysosomal degradation [9] . There are three common apoE alleles, ε2, ε3 and ε4, which arise from single nucleotide polymorphisms and have frequencies of about 8, 77 and 15 %, respectively, in Caucasian populations [9] . Each isoform has physiologically distinct receptor binding affinities, reflecting amino acid substitutions, R158C (apoE2) and C112R (apoE4) [9] [10] [11] . Brain has the second highest level of apoE mRNA, most being synthesized by astrocytes and microglia [12] .
ApoE fulfills several functions in brain, all mediated via receptor-binding: maintenance of cholesterol homeostasis; a targeting protein for local cholesterol redistribution within tissue undergoing repair or re-modelling; an emerging role in developmental processes; and synapse formation [13, 14] ..
The well-established pathological hallmarks of AD are the deposition of β-amyloid (Aβ) in plaques and the accumulation of neurofibrillary tangles, both of which are neurotoxic and contribute to progressive neurodegeneration. The role of apoE in these events is unclear, although it co-localizes with amyloid-rich neuritic plaques in AD brains [15, 16] and accumulates in regions of damaged or regenerating nerves, perhaps to scavenge and return released cholesterol for axonal regeneration [17] . Studies in vitro and in transgenic mouse models [18] underline extensive roles for apoE in neurobiology and also reveal isoform differences. In some cases apoE3 fulfills protective functions, in a manner that apoE4 cannot;
for example, in binding and stabilising microtubules to inhibit hyperphosphorylation of tau [14, [18] [19] [20] , and in promoting neurite extension which apoE4 impedes [21, 22] . In others, apoE4
is neurotoxic, for example by forming stable complexes with Aβ [15, 16] or enhancing fibrillization of Aβ peptides to generate neuritic plaques [18] .
In the brain, nitric oxide (NO) is a ubiquitous intercellular messenger that can modulate cerebral blood flow, thrombosis and neurotransmitter release as well as contributing to morphogenesis and synaptic plasticity [23, 24] . In excess, however, it is volatile and reacts rapidly with superoxide to form peroxynitrite, a potential mediator of cyto-and neurotoxicity by nitration of amino acids and oxidation of lipids, proteins and DNA [25, 26] . We have previously shown in platelets [27] and endothelial cells [28] that binding of apoE by one of its receptors, apoE receptor 2 (apoER2), can initiate a signalling cascade which upregulates endothelial nitric oxide synthase (NOS3) activity and NO production. Furthermore, this effect is isoformdependent with apoE4 releasing much less NO than apoE3 [29] .
We hypothesise that apoE will also stimulate NO biosynthesis in neuronal cells and that apoE4 will generate inappropriate amounts compared to apoE3. As a prelude, we have quantified mRNA transcripts of lipoprotein receptors that bind apoE, including apoER2 and scavenger receptor class B, types I and II (SR-BI and SR-BII), using real-time PCR and a diverse panel of human cells, as well as neuronal and astrocytic cell lines. Expression of the three NOS isoenzymes and Akt, the NOS3 regulatory kinase, were also studied. We found that brain cells had the highest levels of apoER2 mRNA and intriguingly that SR-BII predominated over the more common splice variant, SR-BI. The findings also identified suitable cell lines for investigating apoE-dependent biosynthesis of NO in the brain: H4 neuroglioma, IMR-32 neuroblastoma, SH-SY-5Y neuroblastoma and CCF-STTG1 astrocytoma cells.
Materials and Methods

Optimization of PCR conditions
Prior to quantitative assays, PCR primers and conditions were established by standard PCR using DNA templates from CCF-STTG1 astrocytoma and SH-SY-5Y neuroblastoma cells.
These were cultured in RPMI 1640 and Dulbecco's modified Eagle's media (Sigma), respectively, supplemented with 10% fetal calf serum and 2mM glutamine (both Life Technologies), at 37°C in a 5% CO 2 saturated incubator. Cells were passaged when 70-80% confluent (usually 2-3 times a week) and DNA was extracted using a commercial kit (Qiagen DNeasy 
Preparation of TaqCell plates
Analysis of gene expression was performed using a human cell line and primary cell 'TaqCell' masterplate. Briefly, total RNA was extracted from 38 cell lines, including two neuroblastoma cell lines, IMR-32 and SH-SY-5Y, which were also differentiated into more neuron-like morphologies with extended neurites (Table 2 ). This was achieved by treating IMR-32 cells for 7 days with 1µM retinoic acid, and by supplementing SH-SY-5Y growth medium for 7 days with 1mM dibutryl cAMP, 100ng/ml 2.5S nerve growth factor, 10µg/ml gangliosides, and 0.5µM sodium butyrate. Each RNA (50µg) was reverse transcribed using oligo-(dT) 12-18 and SuperScript II reverse transcriptase (Life Technologies) and the cDNA diluted into 96-well plates. The plates with wells containing 5µl of cDNA reverse transcribed from 50ng total RNA from the different cells were then stored at -80ºC until use.
Quantitative RT-PCR on TaqCell plates
To each well of cDNA template (5µl), a 20µl reaction mix was added containing 12.5µl '2x PCR mastermix' (comprising optimal amounts of SYBR Green I, MgCl 2 , dNTP and Taq polymerase), 1µl of 10µM forward primer, 1µl of 10µM reverse primer, and 5.5µl water. PCR assays were performed in duplicate on an ABI 7700 Sequence Detection system (Applied Biosystems) running the cycling conditions: 50ºC for 2 min, 95ºC for 10 min, 45 cycles of 95ºC for 15 s, and 60ºC for 1 min. Immediately following this reaction, melt curve analysis was performed by heating the plate from 60ºC to 99ºC and measuring SYBR Green I dissociation from the amplicons. This allowed determination of reaction specificity where a single peak in a first derivative plot was indicative of a single amplification product, whereas multiple peaks implied co-amplification of several cDNA species. The copy number of mRNA-derived cDNA in each sample was calculated from a standard curve generated with the use of known amounts of plasmid or genomic DNA. Housekeeping genes, β-actin and GAPDH, were measured for reference to verify that all samples were integral and of comparable quality. Genomic DNA contamination of the original RNA samples was negligible (<10 copies genomic DNA/50ng RNA), as shown by TaqMan assay of genomic sequence for 10 genes in replicate samples taken through the reverse transcription procedure, but with the reverse transcriptase omitted.
Results
Standard PCR assay to test primers
Before primers were used in TaqCell plate assays, it was important to verify that each chosen pair would selectively amplify their target under identical conditions. This was done using cDNA templates from CCF-STTG1 and SH-SY-5Y cells and performing reactions in a standard thermocycler, in some cases evaluating several primer pairs for each target. The final ones selected all showed clear, single-band products by electrophoretic gel analysis for each lipoprotein receptor (Fig. 1A) , and also for the NOS isoforms and PKB/Akt (Fig. 1B) , without obvious contamination by artefactual bands, mispriming, or primer-dimer complexes. A reaction using validated TaqCell primers for the housekeeping gene, β-actin, as a positive control, also gave a single band (Fig, 1B ).
Expression of LDL-receptor family members
Expression of the low-density lipoprotein receptor (LDL-r) was observed in all cell lines ( Fig. 2A ). With few exceptions, copies of mRNA detected exceeded 100,000/50ng total RNA across the whole plate, with UT7-Epo cells having the highest level. Expression levels in the brain-derived cells did not obviously differ from the other cell lines. The VLDL-r showed a distinct expression profile ( Fig. 2B) , with large differences in mRNA levels between cell types.
The highest levels of gene expression were generally in cells from the vessel wall, while brainderived cells also displayed strong expression, both in astrocytoma and neuroblastoma cells. In the two differentiated neuroblastoma cells, expression of the VLDL-r was upregulated, 2.9-times in IMR-32 and 1.5-times in SH-SY-5Y. Similar upregulation was also seen in AOSMC smooth muscle cells (2.9-times higher) following serum stimulation.
Although all cell lines expressed LRP, mRNA levels across the TaqCell plate were highly cell-dependent, with vessel wall-derived cell lines and macrophages giving the highest copy numbers (Fig. 2C) . As with VLDL-r expression, there was upregulation of LRP in the differentiated brain-derived cell lines, markedly so for IMR-32 cells (32-times), while expression in SH-SY-5Y cells doubled. ApoER2 mRNA was detected at a lower level than the other LDL-r gene family members (Fig. 2D ). However, a survey across the plate revealed that both astrocytoma and neuroblastoma cell lines displayed high apoER2 expression, relative to the other cell types, with the greatest level found in H4 neuroglioma cells. Differentiated IMR-32 cells showed a 30% rise in apoER2 mRNA, consistent with increased expression of LDL-r and VLDL-r, whereas this was not seen in SH-SY-5Y cells, which expressed 55% less apoER2
mRNA than undifferentiated cells.
Expression of HDL receptors, SR-BI and SR-BII
Expression of the high-density lipoprotein (HDL) receptors, SR-BI ( However, this preferential expression of SR-BII was confined to neuroblastoma cells, as each of the four astrocytoma cell lines had higher copy numbers of SR-BI mRNA than SR-BII mRNA.
In three cells, differentiated IMR-32, SK-N-SH and NT-2 precursor cells, there was over 30-times greater expression of SR-BII than SR-BI. These findings contrast with previous reports of the proportional distribution of these receptors in other tissues [30] , and with our present survey across a wide range of cell types.
Expression of NOS isoforms and PKB/Akt
The three NOS isoform mRNAs were detected at lower levels than those of the lipoprotein receptors, rarely exceeding 4,000 mRNA copies detected/50ng total RNA. NOS1 mRNA was detected at the lowest level with several of the brain-derived cell lines showing no expression (Fig. 4A) . SH-SY-5Y cells gave the highest level of 430 mRNA copies detected (and was also highest across the whole plate; data not shown), although upon differentiation there was a dramatic decrease in NOS1 mRNA expression. NOS2 mRNA was detected in all the brainderived cells with half showing a 'basal' expression level of ~400 mRNA copies detected/ 50ng
total RNA (Fig. 4B) , which was similar to that detected in the other cell types on the plate (data not shown). NOS3 mRNA was also readily detected and ten of the twelve brain-derived cells gave a consistent expression level of 1500-3000 mRNA copies detected/ 50ng total RNA. The two exceptions, C13 and differentiated IMR-32 cells, gave levels of 4,200 and 8,000 mRNA copies detected/ 50ng total RNA, respectively (Fig. 4C) . For both NOS2 and NOS3, the two differentiated cell lines showed similar changes in mRNA expression compared to their undifferentiated counterparts. In the case of IMR-32 cells differentiation produced 3-4-fold increases in NOS2 and NOS3 expression, while in SH-SY-5Y cells the change was in the opposite direction with differentiation leading to halving of mRNA copy numbers (Fig. 4B,C) .
Expression of Akt mRNA (Fig. 4D) was usually high across all cell types on the TaqCell plate, many cell lines having an expression level fluctuating marginally around the mean of 100,000 mRNA copies detected/ 50ng total RNA. Most brain-derived cells also showed good expression of Akt mRNA, with values similar to other cell lines and in some cases exceeding them. The three highest expressing lines were the 1321N1, C13 and CCF-STG1 astrocytoma cells, which each gave levels of ~120,000 mRNA copies detected/ 50ng total RNA.
Differentiation of IMR-32 and SH-SY-5Y cell lines produced 170% and 40% increases in expression, respectively, to about 80,000 mRNA copies detected/ 50ng total RNA compared to the undifferentiated forms.
Discussion
This study has used quantitative RT-PCR to measure mRNA expression levels of a range of genes involved in apoE metabolism and NO biosynthesis, focusing on genes encoding receptors capable of binding apoE-containing lipoproteins. To our knowledge, this is the first such survey of gene expression, covering an extensive and diverse range of human tissue cell lines, including those derived from brain-cells. The generic probe, SYBR Green I, which intercalates into the double-strand DNA amplicons, was used to monitor PCR reactions rather than a synthetic oligonucleotide-based reagent specific for each gene. However, all assays were sensitive and specific, as judged by rigorous electrophoretic and melt curve analyses of primer pairs prior to their use in TaqCell plates. Nevertheless, individual assays give only information on mRNA levels; in particular, whether a gene is expressed by a cell line, and its copy number relative to other cell lines and to other genes investigated. It does not follow, however, that mRNA levels are a true reflection of protein expression; an important consideration when evaluating the data and for future studies.
The LDL-r is the archetypical cell-surface receptor mediating endocytosis of its ligand, in this case apoE or apoB100 which deliver lipid nutrients. It is expressed in virtually all cells and tissues at variable levels, which our findings in TaqCell plates confirm. The LDL-r is widely expressed in brain and, as apoB100 and LDL are absent from cerebrospinal fluid [31] , it appears that their role in lipid transport and cholesterol homeostasis is fulfilled by apoE [17, 31] .
Structurally, the VLDL-r and apoER2 are very similar to the LDL-r and to each other; both bind apoE3 and apoE4 with similar affinities [32, 33] . The VLDL-r is abundantly expressed in heart and skeletal muscle and adipose, which all actively metabolize fatty acids acquired from triglyceride-rich lipoproteins [34, 35] , whereas apoER2 is absent from these tissues and reported to predominate in brain, with a widespread distribution [36] . Subsequent immunohistochemical studies also revealed VLDL-r expression in brain, including hippocampal cortical neurons and microglia, particularly those associated with senile plaques [37, 38] . Data from our TaqCell plates were consistent with this tissue distribution, including the strong expression of VLDL-r and apoER2 across most of the brain-derived cell lines.
Studies in mice that lack both VLDL-r and apoER2 have highlighted key roles for these receptors in neuronal migration and development of the nervous system. The double knockout mice have marked behavioural and neuroanatomical features, which includes cerebellar dysplasia and severe ataxia, and disruption of cortical layering. This phenotype is identical to the mutant mouse strains, Scrambler and Reeler, which have dysfunctional forms of the intracellular adaptor protein, Disabled-1 (Dab-1) [39] , and the large secreted signalling glycoprotein, Reelin [39, 40] , respectively. Genetic and biochemical studies now group these disparate proteins into a common signalling pathway in which Reelin binds with high-affinity to VLDL-r or apoER2, an interaction which promotes Dab-1 binding to the cytoplasmic NPxY motifs of both receptors [14] . This initial Reelin signal stimulates tyrosine phosphorylation of Dab-1, which in turn can then activate a variety of downstream signalling components [14, 41, 42] .
At 600-kDa, LRP is much larger than the other LDL-r family members studied and contains two NPxY motifs and one tyrosine-based YxxL motif. It has broad binding specificity with over 30 different ligands many of which are internalized, interestingly via the alternative endocytic signalling motif, YxxL, which dominates [43] . In addition, several adaptor and scaffold proteins, including Dab-1, potentially bind the cytoplasmic NPxY motifs of LRP and, although biochemical and physiological details are incomplete, numerous regulatory functions are suggested, including mitogen-activated protein (MAP) kinase signalling, ion channel function, microtubular transport, and axon guidance [41, 44, 45] . Genetic association studies suggest a direct link between LRP and AD, as the C766T polymorphism in exon 3 of LRP is under-represented [46] . However, although brains of AD patients with CT or TT genotypes contain higher levels of LRP [47] and circumstantial evidence suggests that LRP promotes Aß clearance [48] , the relationship remains controversial [49] . Similarly, polymorphisms in the VLDL-r [37, 38] and apoER2 [50] have been identified and are suggested to be risk factors for AD, but further studies are needed to verify these possibilities.
Scavenger receptor class B, type I mediates the selective uptake of cholesteryl esters from HDL without degrading the particles. It was the first authentic HDL binding protein to be characterized [51] , although other ligands including apoE are now recognized [52] . A splice variant, termed SR-BII, was subsequently identified; this results from exon 12 skipping [30, 53] to produce a receptor with a different C-terminal cytoplasmic tail, but identical extracellular binding region, to that of SR-BI. This implies differential functions; for example, the interaction between C-terminal SR-BI and PDZK1, a scaffolding protein [54] , would not occur with SR-BII. On the other hand, cytoplasmic SR-BII contains six PxxP motifs, two being conserved in rat, mouse and hamster, which are potential ligands for tyrosine kinases or adaptor proteins with Src homology 3 (SH3) domains [30] . The presence of these motifs, which are also seen in cytoplasmic apoER2 [55] , suggests that SR-BII may initiate signalling pathways that cannot be mediated by SR-BI; an exciting possibility given the preferential expression of SR-BII in many brain-derived cell lines (Fig. 3C ).
Copy numbers of NOS mRNA transcripts were generally low in all cells, although presumably adequate to maintain basal NO levels that are biologically functional without being cyto-or neurotoxic. Under normal physiological conditions, relatively little NO is synthesized and it appears that cells only transcribe NOS genes at low levels. Indeed, production of NO commonly reflects the catalytic activity of the enzyme, which depends on intracellular Ca 2+ concentrations, the availability of substrates or co-factors, and an array of heterologous protein partners [56] . Both NOS1 and NOS3 are constitutively transcribed, whereas NOS2 expression is induced by cytokines, such as IFN-γ. Recently, phosphorylation at Ser 1177 has emerged as a key regulatory mechanism of NOS3 activity, most likely because the enzyme can then bind calcium-activated calmodulin at low calcium concentration. The phosphorylation of NOS3 can be mediated by protein kinase A (PKA) or AMP kinase, but is accomplished more frequently by protein kinase B (PKB; usually termed Akt), which also helps regulate apoptosis and cellular proliferation and is itself phosphorylated and activated by phosphatidylinositol (PI) 3-kinase [57] . Here, we have measured NOS and Akt mRNA transcripts in each cell line, which as discussed above may not accurately reflect protein levels. Thus, although our data identify cells that express the three isoenzymes and the key activator of NOS3, the measurement of NOS proteins and a functional assessment of NO synthesis must await additional investigations.
In summary, our study has demonstrated that receptors recognizing apoE are widely expressed in brain-derived cell lines. Of note were the strong expression of apoER2 in these cells, which we have previously implicated in apoE-mediated stimulation of NO release in platelets and endothelium, and the preferential expression of SR-BII, which is rich in cytoplasmic SH3 motifs, over the normal splice variant, SR-BI. Our findings also identified H4 neuroglioma, IMR-32 neuroblastoma, SH-SY-5Y neuroblastoma and CCF-STTG1 astrocytoma cells as being suitable human brain cells for investigating apoE-dependent biosynthesis of NO and whether apoE4 and apoE3 have differential effects. Table 2 Human 
